{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:19:26Z","timestamp":1790252366041,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.braindev.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T05:50:49Z","timestamp":1544075449000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of pyridoxal in West syndrome: A retrospective study"],"prefix":"10.1016","volume":"41","author":[{"given":"Ryuki","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ikemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Koichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2018.11.010_b0005","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2018.11.010_b0010","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/WNL.52.8.1691","article-title":"ACTH versus vigabatrin therapy in infantile spasms: a retrospective study","volume":"52","author":"Cossette","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2018.11.010_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0887-8994(91)90003-4","article-title":"Vitamin B6 and valproic acid in treatment of infantile spasms","volume":"7","author":"Ito","year":"1991","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2018.11.010_b0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1528-1157.1993.tb00458.x","article-title":"Treatment of infantile spasms with high-dosage vitamin B6","volume":"34","author":"Pietz","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.11.010_b0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0887-8994(00)00185-5","article-title":"Long-term follow-up of vitamin B(6)-responsive West syndrome","volume":"23","author":"Ohtsuka","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2018.11.010_b0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0387-7604(01)00292-3","article-title":"High-dose vitamin B(6) treatment in West syndrome","volume":"23","author":"Toribe","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.11.010_b0035","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/0883073812455692","article-title":"Pediatric epilepsy research consortium, section on infantile spasms. The current evaluation and treatment of infantile spasms among members of the Child Neurology Society","volume":"27","author":"Mytinger","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2018.11.010_b0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2003.045963","article-title":"Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy","volume":"90","author":"Wang","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.braindev.2018.11.010_b0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.braindev.2018.04.006","article-title":"Treatment of infantile spasms by pediatric neurologists in Japan","volume":"40","author":"Hamano","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.11.010_b0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0387-7604(87)80116-X","article-title":"Treatment of the West syndrome with high-dose pyridoxal phosphate","volume":"9","author":"Ohtsuka","year":"1987","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.11.010_b0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1528-1157.1973.tb03953.x","article-title":"Treatment of infantile spasms and Lennox-Gastaut syndrome with clonazepam (Rivotril)","volume":"14","author":"Vassella","year":"1973","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.11.010_b0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1528-1157.1988.tb03760.x","article-title":"Therapy of infantile spasms with valproate: results of a prospective study","volume":"29","author":"Siemes","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.11.010_b0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpeds.2006.12.004","article-title":"Developmental outcomes of cryptogenic West syndrome","volume":"150","author":"Hamano","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2018.11.010_b0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1528-1157.1996.tb00573.x","article-title":"Long-term outcome of West syndrome: A study of adults with a history of infantile spasms","volume":"37","author":"Riikonen","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.11.010_b0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3476(05)81379-4","article-title":"High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms","volume":"124","author":"Hrachovy","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2018.11.010_b0080","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1212\/WNL.54.12.2346-a","article-title":"Subdural hematoma during low-dose ACTH therapy in patients with west syndrome","volume":"54","author":"Ito","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2018.11.010_b0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2008.01.004","article-title":"Pyridoxal 5'-phosphate values in cerebrospinal fluid: reference values and diagnosis of PNPO deficiency in paediatric patients","volume":"94","author":"Ormazabal","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2018.11.010_b0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418304741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418304741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T15:44:14Z","timestamp":1553960654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760418304741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0387760418304741"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2018.11.010","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of pyridoxal in West syndrome: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}